Universidad Francisco de Vitoria
ufv.esTotal trials
52
Active
12
Phase 3
0
Total enrollment
2,048
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Parkinson Disease5
- Placebo4
- Frailty Syndrome3
- Geriatric Health3
- Respiratory Muscle Weakness3
- Age-Related Frailty3
- Pain3
- Dietary Supplement3
Frequently asked questions about Universidad Francisco de Vitoria
- How many clinical trials does Universidad Francisco de Vitoria have on ClinicalTrials.gov?
- Universidad Francisco de Vitoria is listed as the lead sponsor on 52 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Universidad Francisco de Vitoria's trials are in Phase 3?
- 0 of Universidad Francisco de Vitoria's trials are in Phase 3.
- What therapeutic areas does Universidad Francisco de Vitoria focus on?
- Universidad Francisco de Vitoria's most-studied conditions on ClinicalTrials.gov are Parkinson Disease, Placebo, Frailty Syndrome, Geriatric Health, Respiratory Muscle Weakness.